India's Alkem Labs drops as Q3 earnings miss view; J.P. Morgan flags weak outlook

Alkem Laboratories

10/02/2025 05:46

** Shares of Alkem Labs  ALKE.NS  down 6.4% to 5,151 rupees
    ** Stock top percentage loser on the Nifty Pharma index
 .NIPHARM , which is down 1.8%
    ** The pharma co posted a 5.2% YoY increase in quarterly net
profit and a 1.5% rise in revenue on Friday, but both fell short
of analysts' estimates
    ** Brokerage J.P. Morgan cuts its FY25/26/27 earnings
estimates by 4%/3%/8% due to softer revenue trends
    ** Co maintained FY25 EBITDA margin target at 19%,
indicating a weak Q4 ahead - J.P. Morgan 
    ** Brokerage adds, concerns remain due to weak India growth
and lackluster U.S. portfolio    
    ** Stock rose 8.3% in 2024 vs a 39% gain in  .NIPHARM 




 (Reporting by Yagnoseni Das in Bengaluru)
 ((Yagnoseni.Das@thomsonreuters.com;))